- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT06001918
Étude clinique du système Nectero EAST (stAAAble)
Essai clinique contrôlé randomisé (ECR) du système Nectero EAST pour la stabilisation des anévrismes de l'aorte abdominale (AAA) de petite et moyenne taille : évaluation de l'efficacité.
The purpose of this randomized clinical trial is to treat patients with small to mid-sized abdominal aortic aneurysms (AAA), maximum diameter of 3.5 cm to 5.0 cm, using a locally delivered, single-dose endovascular treatment. The main question the study aims to answer is to demonstrate efficacy of the product for stabilization of these small to mid-sized AAA.The study will compare the treatment group to the typical standard of care for these patients, surveillance. All subjects will be followed at designated intervals at 30/60 days, 6, 12, 18 and 24 months with continued follow-up annually for up to 5 years.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- Phase 2
- Phase 3
Contacts et emplacements
Coordonnées de l'étude
- Nom: Charlene Knape
- Numéro de téléphone: 866-755-4744
- E-mail: cknape@necteromedical.com
Sauvegarde des contacts de l'étude
- Nom: Tracy Roberts
- Numéro de téléphone: (303)3964603
- E-mail: troberts@necteromedical.com
Lieux d'étude
-
-
New South Wales
-
Randwick, New South Wales, Australie, 2031
- Recrutement
- Prince of Wales Private Hospital- POW Vascular Institute
-
Chercheur principal:
- Ramon Varcoe
-
Contact:
- Jade Goh
- Numéro de téléphone: 04 87 369 396
- E-mail: pow.vascular.institute@gmail.com
-
-
-
-
-
Auckland, Nouvelle-Zélande, 1023
- Recrutement
- Auckland City Hospital
-
Contact:
- Cynthia Corne
- Numéro de téléphone: 21505 +64 9 307 4949
- E-mail: CorneC@adhb.govt.nz
-
Chercheur principal:
- Andrew Holden, A/Prof
-
-
-
-
Arizona
-
Scottsdale, Arizona, États-Unis, 85258
- Recrutement
- Honor Health Scottsdale Shea Medical Center
-
Chercheur principal:
- Hasan Aldailami, MD
-
Contact:
- HonorHealth Cardiovascular Research
- Numéro de téléphone: 480-323-1046
-
-
Colorado
-
Aurora, Colorado, États-Unis, 80045
- Actif, ne recrute pas
- University of Colorado
-
-
District of Columbia
-
Washington D.C., District of Columbia, États-Unis, 20010
- Recrutement
- Medstar Washington Hospital Center
-
Chercheur principal:
- Steven Abramowitz, MD
-
Contact:
- Kassaye Sesaba, MD
- Numéro de téléphone: 202-877-7452
- E-mail: Kassaye.T.Sesaba@medstar.net
-
Contact:
- Suman Singh, MD
- Numéro de téléphone: (202) 877-8475
- E-mail: Suman.Singh@Medstar.net
-
-
Florida
-
Delray Beach, Florida, États-Unis, 33446
- Recrutement
- Prime Vascular Institute
-
Chercheur principal:
- Joseph Ricotta, MD
-
Contact:
- Jordan Sprechman
- Numéro de téléphone: 561-495-3145
- E-mail: Jordan.Sprechman@tenethealth.com
-
Contact:
- Alexia Medick
- E-mail: Alexia.Medick@tenethealth.com
-
-
Georgia
-
Augusta, Georgia, États-Unis, 30912
- Recrutement
- Medical College of Georgia
-
Chercheur principal:
- William Jordan, MD
-
Contact:
- Natasha Flores
- E-mail: nflores@augusta.edu
-
Contact:
- Candelario Laserna
- Numéro de téléphone: 706-721-2199
- E-mail: calaserna@augusta.edu
-
-
Illinois
-
Chicago, Illinois, États-Unis, 60637
- Recrutement
- University of Chicago
-
Contact:
- MacKenton Johnson
- Numéro de téléphone: 773-795-3639
- E-mail: mackenton@bsd.uchicago.edu
-
Chercheur principal:
- Ross Milner, MD
-
Elk Grove, Illinois, États-Unis, 60007
- Pas encore de recrutement
- Ascension Alexian Brothers
-
Chercheur principal:
- Jack Chamberlin, MD
-
-
Maine
-
Scarborough, Maine, États-Unis, 04074
- Recrutement
- MaineMed Vascular Surgery
-
Chercheur principal:
- Kristina Giles, MD
-
Contact:
- Kathryn Ackermann
- E-mail: kathryn.ackermann@mainehealth.org
-
-
Massachusetts
-
Boston, Massachusetts, États-Unis, 02114
- Recrutement
- Massachusetts General Hospital
-
Chercheur principal:
- Nikolaos Zacharias, MD
-
Contact:
- Bonnie Chen
- E-mail: BCHEN13@mgh.harvard.edu
-
Boston, Massachusetts, États-Unis, 02215
- Recrutement
- Beth Israel Deaconess Medical Center
-
Chercheur principal:
- Marc Schermerhorn, MD
-
Contact:
- Monica Goyal
- Numéro de téléphone: 617-632-7534
- E-mail: mgoyal@bidmc.harvard.edu
-
Contact:
- Fernando Moreno
- E-mail: fmoreno@bidmc.harvard.edu
-
Worcester, Massachusetts, États-Unis, 01655
- Recrutement
- University of Massachusetts
-
Contact:
- Shauneen Valliere
- E-mail: shauneen.valliere@umassmed.edu
-
Chercheur principal:
- Andres Schanzer, MD
-
-
Michigan
-
Royal Oak, Michigan, États-Unis, 48073
- Recrutement
- Beaumont Health
-
Chercheur principal:
- Graham Long, MD
-
Contact:
- Lisa Bliss
- E-mail: lisa.bliss@corewellhealth.org
-
-
Missouri
-
St Louis, Missouri, États-Unis, 63110
- Recrutement
- Washington University School of Medicine
-
Chercheur principal:
- Luis Sanchez, MD
-
Contact:
- Briana K Langrehr, BSN
- E-mail: briana.l@wustl.edu
-
-
Nebraska
-
Omaha, Nebraska, États-Unis, 68198
- Recrutement
- University of Nebraska Medical Center
-
Chercheur principal:
- Jonathan Thompson, MD
-
Contact:
- Jarod Phillips
- E-mail: jarphillips@unmc.edu
-
-
New Hampshire
-
Lebanon, New Hampshire, États-Unis, 03766
- Recrutement
- Dartmouth Hitchcock Medical Center
-
Chercheur principal:
- Rebecca Scully, MD
-
Contact:
- Pauline Sirrell
- E-mail: pauline.sirrell@hitchcock.org
-
-
New York
-
Rochester, New York, États-Unis, 14642
- Recrutement
- University of Rochester
-
Contact:
- Mary Bourret
- E-mail: Mary_Bourret@URMC.Rochester.edu
-
Chercheur principal:
- Doran Mix, MD
-
Stony Brook, New York, États-Unis, 11794
- Pas encore de recrutement
- Stony Brook Medicine
-
Chercheur principal:
- Rabih Chaer, MD
-
Contact:
- Daria Shavarina
- E-mail: Daria.Shavarina@stonybrookmedicine.edu
-
-
North Carolina
-
Durham, North Carolina, États-Unis, 27710
- Recrutement
- Duke University Medical Center
-
Chercheur principal:
- Chandler Long, MD
-
Contact:
- Ellen Burkett
- Numéro de téléphone: (919)681-1878
- E-mail: ellen.jones@duke.edu
-
-
Ohio
-
Cincinnati, Ohio, États-Unis, 45219
- Recrutement
- The Christ Hospital
-
Contact:
- Jamie Elkins
- E-mail: Jamie.Elkins@thechristhospital.com
-
Chercheur principal:
- Geoff Answini, MD
-
Cleveland, Ohio, États-Unis, 44106
- Recrutement
- University Hospitals Cleveland
-
Chercheur principal:
- Jae Cho, MD
-
Contact:
- Amy Kluge
- E-mail: Amy.Kluge@UHhospitals.org
-
Cleveland, Ohio, États-Unis, 44195
- Recrutement
- Cleveland Clinic
-
Chercheur principal:
- Francis Caputo, MD
-
Contact:
- Laurie Ann Moennich
- E-mail: MOENNIL@ccf.org
-
Columbus, Ohio, États-Unis, 43210
- Recrutement
- The Ohio State University Wexner Medical Center
-
Contact:
- Subh Das
- Numéro de téléphone: 614-366-6596
- E-mail: subhashish.das@osumc.edu
-
Chercheur principal:
- Kristine Orion, MD
-
Columbus, Ohio, États-Unis, 43214
- Recrutement
- Ohio Health Riverside
-
Chercheur principal:
- Joseph Campbell, MD
-
Contact:
- Regan Moran
- E-mail: Regan.Moran@ohiohealth.com
-
-
Oklahoma
-
Tulsa, Oklahoma, États-Unis, 74104
- Recrutement
- Oklahoma Heart Institute
-
Chercheur principal:
- Julia Chen, MD
-
Contact:
- Tia Whitaker
- E-mail: Tia.Whitaker@hillcrest.com
-
-
Oregon
-
Portland, Oregon, États-Unis, 97239
- Recrutement
- Portland VA Medical Center
-
Chercheur principal:
- Matthew Koopmann, MD
-
Contact:
- Rachel Nelson
- E-mail: Rachel.Nelson1@va.gov
-
-
Pennsylvania
-
Bethlehem, Pennsylvania, États-Unis, 18015
- Recrutement
- St. Luke's University Health Network
-
Chercheur principal:
- Sharvil Sheth, MD
-
Contact:
- Jena Hagerty
- Numéro de téléphone: 484-658-4982
- E-mail: Jena.Hagerty@sluhn.org
-
Philadelphia, Pennsylvania, États-Unis, 19104
- Recrutement
- Hospital of the University of Pennsylvania
-
Contact:
- Carolina Reyes
- Numéro de téléphone: 215-615-8036
- E-mail: carolina.reyes1@pennmedicine.upenn.edu
-
Chercheur principal:
- Grace Wang, MD
-
Philadelphia, Pennsylvania, États-Unis, 19107
- Recrutement
- Jefferson Clinical Research Institute
-
Contact:
- Jona Shperdheja
- E-mail: Jona.Shperdheja@jefferson.edu
-
Chercheur principal:
- Michael Nooromid, MD
-
Pittsburgh, Pennsylvania, États-Unis, 15219
- Recrutement
- University of Pittsburgh Medical Center
-
Contact:
- Judith Brimmeier
- E-mail: brimmeierja@upmc.edu
-
Chercheur principal:
- Raymond Eid, MD
-
-
South Carolina
-
Greenville, South Carolina, États-Unis, 29605
- Recrutement
- Prisma Health
-
Chercheur principal:
- Mark P Androes, MD
-
Contact:
- Nikita Kasinger
- E-mail: Nikita.Kasinger@PrismaHealth.org
-
Contact:
- Maggie Salle
- E-mail: Margaret.Salle@PrismaHealth.org
-
-
South Dakota
-
Sioux Falls, South Dakota, États-Unis, 57108
- Recrutement
- North Central Heart - A Division of Avera Heart Hospital
-
Chercheur principal:
- Michael Bacharach, MD
-
Contact:
- Patty Eisenbraun, RN
- Numéro de téléphone: 605-977-5336
- E-mail: peisenbraun@ncheart.com
-
-
Tennessee
-
Nashville, Tennessee, États-Unis, 37232
- Recrutement
- Vanderbilt University Medical Center
-
Chercheur principal:
- John Curci, MD
-
Contact:
- Celia Nunez
- E-mail: celia.m.nunez@vumc.org
-
Contact:
- Jennifer Scott
- E-mail: jennifer.scott@vumc.org
-
Nashville, Tennessee, États-Unis, 37212
- Pas encore de recrutement
- VA Tennessee Valley Healthcare System
-
Chercheur principal:
- John Curci, MD
-
Contact:
- Sohpia Miner
- E-mail: Sophia.Miner@va.gov
-
-
Texas
-
Houston, Texas, États-Unis, 77004
- Recrutement
- Houston Healthcare
-
Chercheur principal:
- Kristofer Charlton-Ouw, MD
-
Contact:
- Swathi Potla
- E-mail: swathi.potla@hcahealthcare.com
-
Plano, Texas, États-Unis, 75093
- Recrutement
- Baylor Scott & White Medical Center
-
Chercheur principal:
- William Shutze, MD
-
Contact:
- Saba Arianpour
- E-mail: Saba.Arianpour@BSWHealth.org
-
-
Utah
-
Salt Lake City, Utah, États-Unis, 84132
- Recrutement
- University of Utah Hospital
-
Contact:
- Julie Hales
- E-mail: Julie.Hales@hsc.utah.edu
-
Chercheur principal:
- Cali Johnson, MD
-
-
Virginia
-
Fairfax, Virginia, États-Unis, 22031
- Recrutement
- Inova Fairfax Medical Campus Inova Health Systems
-
Contact:
- Bhruga Shah
- E-mail: Bhruga.shah@inova.org
-
Chercheur principal:
- Kendal Endicott, MD
-
Norfolk, Virginia, États-Unis, 23507
- Recrutement
- Sentara Health
-
Chercheur principal:
- David Dexter, MD
-
Contact:
- Angela Zahn
- E-mail: AXZAHN@sentara.com
-
-
Washington
-
Seattle, Washington, États-Unis, 98104
- Recrutement
- University of Washington at Harborview Medical Center
-
Contact:
- Allison Larimore
- E-mail: alari@uw.edu
-
Chercheur principal:
- Benjamin Starnes, MD
-
-
Wisconsin
-
Green Bay, Wisconsin, États-Unis, 54301
- Recrutement
- Bellin Memorial Hospital
-
Chercheur principal:
- Jason Ricci, MD
-
Contact:
- Katie Guilliams
- E-mail: Katherine.Guilliams@emplifyhealth.org
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Males and females ≥21 to ≤85 years of age. Females must be of non-childbearing potential (menopause or sterilization).
- Subject understands the purpose of the trial, agrees to voluntarily participate in the trial, signs the informed consent and is willing to complete the follow-up according to the requirements of the protocol.
- Infrarenal atherosclerotic fusiform abdominal aortic aneurysm from 3.5 cm to 5.0 cm (male) and 3.5 cm to 4.5 cm (female).
- Infrarenal aortic neck ≥ 15 mm in length and ≤ 29 mm in diameter.
- Overall AAA treatment length (distal renal to distal inferior margin of the aneurysm) not to exceed 130 mm.
- Iliac and femoral artery access, vessel size and morphology allow endovascular access of 14F (or larger) introducer sheaths and catheters.
- Subject meets American Society of Anesthesiology (ASA) grade 1 through 3 criteria, inclusive.
- Subject has > three-year life expectancy.
- Subject is able and willing to comply with all required follow-up clinic visits including CT scans (pre-randomization, 6, 12, 18, 24 months and annually up to 5 years) and blood draws.
Exclusion Criteria:
- Subject has an acutely ruptured, leaking, dissecting or emergent aneurysm.
- Subject has a symptomatic infrarenal abdominal aortic aneurysm.
- Subject has a mycotic or infected aneurysm.
- Subject has current vascular injury due to trauma.
- Subject's aneurysm is thoracic, suprarenal or juxtarenal.
- Previous surgical or endovascular aneurysm repair for abdominal aortic aneurysm.
- Subject has anatomy of diffuse, ulcerated, or extensive (shaggy) thrombus in the neck of the AAA, that in the opinion of the vascular surgeon/investigator, could result in embolization of the thrombus.
- Subject has anatomy of calcification, and/or plaque within the ilio-femoral arteries or severe infrarenal neck angulation that may compromise or does not allow delivery of the Introducer Sheath or the delivery catheter of the Nectero EAST System.
- Subject has had a myocardial infarction within six (6) months prior to enrollment or elevated CK enzymes or troponin indicative of an evolving MI prior to procedure.
- Subject has current angina, unstable angina, or other active cardiac condition such as congestive heart failure III and IV, atrial arrhythmia, ventricular arrhythmia, or valvular disease, requiring intervention.
- Subject has undergone other major surgery within the 30 days prior to enrollment.
- Subjects with any transient ischemic attack (TIA) or ischemic stroke within 3 months.
- Known allergy to contrast material that cannot be adequately premedicated, delivery system materials (i.e., nylon, polyurethane) and/or pentagalloylglucose (PGG).
- Subject is morbidly obese or has other clinical conditions that severely inhibit X-ray visualization of the aorta.
- Subject has connective tissue/collagen disorder (e.g., Marfan syndrome, vascular Ehlers-Danlos Syndrome, Loeys-Dietz Syndrome, Eaton Syndrome, Bessel-Hagen disease, etc.).
- Known contraindication to undergoing angiography or receiving systemic anticoagulation during the procedure.
- Subject has active systemic infection.
- Subject is participating in another research trial that could interfere with the results of the trial (e.g., drug trial).
- Subject has other medical, social, or psychological problems that, in the opinion of the investigator, preclude them from participation in the trial and to undergo the procedures and evaluations pre- and post-treatment.
- Subject has dialysis dependent renal failure or baseline serum creatinine level >2.5mg/dL or eGFR < 45 mL/min/1.73m2.
- Subjects with aminotransferase (ALT and/or AST) which is ≥1.5x upper limit of normal (ULN) or TB that is our of normal range for the evaluating laboratory.
- Subjects that may not tolerate the lowering of their systolic blood pressure to approximately 100mmHg, should not be considered for this study or treated using the Nectero EAST System.
- Subjects that may not be able to tolerate transient occlusion of the aorta should not be considered for this study.
- Subjects with saccular AAA.
- Subjects with rapidly expanding AAA (previous diameter increases of ≥0.5 cm in 6-months or ≥1 cm in 1 year) as these should be evaluated for immediate repair.
- Subjects who are not suitable for the Nectero EAST System treatment, as determined by the investigator.
- Subjects with INR out of normal range for the evaluating laboratory for a subject not on anti-coagulant therapy; or INR >3 for a subject on anti-coagulant therapy.
- Subjects with active/acute or a history of unstable chronic liver disease or current liver disease including but not limited to liver transplant, known genetic disorders such as Gilbert syndrome or other liver diseases.
- Subjects with cirrhosis (e.g., known history or new clinical diagnosis by elastography with a fibrosis score of F3 or F4 and/or steatosis grade of S3).
- Subjects with uncontrolled alcohol use disorder or current alcohol use putting them at risk of liver disease: including consumption of above one standard drink per day for women and two standard drinks per day for men.
- Subjects with known right-sided heart failure or pathologically dilated inferior vena cava or hepatic veins indicative of congestive hepatopathy.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Treatment Arm
Participants assigned to the treatment arm will undergo an endovascular procedure using the Nectero EAST System to deliver the Stabilizer Infusion Solution directly inside the aneurysm. This is a one-time local delivery of the product. Following treatment, surveillance of their AAA will be conducted using CT scans at 6 months, 12 months, 18 months, 24 months, and annually for 5 years. Intervention: Drug: Stabilizer |
Treated subjects will undergo an endovascular procedure with the Nectero EAST system and receive the Stabilizer Infusion Solution (drug) within 30 days of the study eligibility by CT scan as a one-time local delivery of the drug. |
|
Aucune intervention: Control Arm
Participants assigned to the control arm will undergo surveillance of their AAA using CT scans at 6 months, 12 months, 18 months, 24 months, and annually for 5 years. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Primary Endpoint
Délai: 24 months
|
The primary endpoint is the composite of all AAA-related death, rupture and repair (open-surgical, EVAR, or clinically indicated for repair as adjudicated by a committee of clinical experts blinded to the assigned arm). |
24 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Growth
Délai: 24 months
|
The growth over time in aneurysm diameter based on CT core laboratory readings. |
24 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Daniel Clair, MD, Vanderbilt University Medical Center
- Chercheur principal: Grace Wang, MD, University of Pennsylvania
Publications et liens utiles
Liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- EAST002
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .